NSEAnalysts/Institutional Investor Meet/Con. Call Updates21 Jul 2026 · 21 Jul 2026, 03:29 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharmaceuticals Limited · GLENMARK
✦ AI SummaryResults
Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of an earnings call for the unaudited financial results for the quarter ended June 30, 2026. The call is scheduled to be held on August 03, 2026, from 8:30 am to 9:30 am IST.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
GLENMARK_21072026152814_SE_Intimation_Earnings_Call_signed.pdf
View document text
July 21, 2026
To, To,
National Stock Exchange of India Limited, BSE Limited,
“Exchange Plaza”, Corporate Relationship Department,
5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring,
Bandra- Kurla Complex Bandra (East), Mumbai P.J. Towers, Dalal Street,
– 400 051 Mumbai – 400 001
NSE Symbol: GLENMARK Scrip Code: 532296
ISIN: INE935A01035 ISIN: INE935A01035
Our Reference No. 32/26-27 Our Reference No. 32/26-27
Dear Sir/ Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 – Intimation of Earnings Call
With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of
Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we wish to inform you that Earnings Call on Unaudited Financial
Results for the quarter ended June 30, 2026, is scheduled to be held as per the details below:
Day Monday
Date August 03, 2026
Time 8:30 am – 9:30 am [IST]
Request you to kindly take the same on record.
Thanking You.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
Rashmi Khandelwal
Company Secretary & Compliance Officer
ACS - 28839
Encl: As above
Glenmark Pharmaceuticals Limited
Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099
T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com
Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com
I N V I T A T I O N
Glenmark Pharmaceuticals Ltd.
Q1 FY 2027 Results Earnings Call
Date: Monday, 03 August 2026
Time: 8:30 am – 9:30 am [IST]
Dial – in Numbers:
Universal Access Number:
+91 22 6280 1298
+91 22 7115 8199
USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448
To pre-register online, please click here
For any clarification, please contact:
Utkarsh Gandhi
E-mail: utkarsh.gandhi3@glenmarkpharma.com
Phone: +91 22 4018 9232